Active-ingredient Dossier
Bendamustine Hydrochloride
Active-ingredient Dossier for Bendamustine Hydrochloride (alkylating agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: BENDAMUSTINE
- Brand: RIBOMUSTIN
- Brand: BENDAMUSTINE JUNO
- Brand: BENDAMUSTINE VIATRIS
- Brand: BENDAMUSTINE
- Therapeutic area: Oncology
- Therapeutic area: Haematology
What is
Bendamustine Hydrochloride Bendamustine Hydrochloride is an alkylating agent.
Australian brands containing
Bendamustine Hydrochloride — BENDAMUSTINE — RIBOMUSTIN — BENDAMUSTINE JUNO — BENDAMUSTINE VIATRIS
Therapeutic areas
Bendamustine Hydrochloride is registered in oncology, with four brands available.
Sponsor landscape
The ingredient is marketed by four sponsors: Arrotex Pharmaceuticals, Juno Pharmaceuticals, Alphapharm, and Janssen-Cilag.
PBS and regulatory activity
One brand containing bendamustine hydrochloride has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 July 2015.